Analyst Ratings and Price Target Adjustments for Blueprint Medicines
As of February 13, 2024, Blueprint Medicines (NASDAQ:BPMC) has received analyst reviews over the past three months, showcasing a diverse ...
© 2024 Stocks Today
Tag: BPMC
JMP Securities Analyst Reiterates Market Outperform Rating and 114 Price Target for Blueprint Medicines
On January 16, 2024, JMP Securities analyst Reni Benjamin expressed his optimism for Blueprint Medicines (NASDAQ:BPMC) by reiterating a Market ...
Diversified Trust Co. Increases Holdings in Blueprint Medicines, Sparking Investor Interest in Precision Therapy Biotech Company
Diversified Trust Co has recently reported an increase in its Blueprint Medicines Co. holdings by 45.7% during the first quarter, ...
Teachers Retirement System of The State of Kentucky Increases Investment in Precision Therapy Company: Blueprint Medicines Co.
On June 19th, 2023, Teachers Retirement System of The State of Kentucky reported that they had lifted their position in ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape